Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Sales | 54,659 | 55,503 | 48,524 | 40,179 | 30,156 |
Cost of Goods | 216 | 639 | 74 | 43 | 333 |
Gross Profit | 54,443 | 54,863 | 48,450 | 40,136 | 29,823 |
Operating Expenses | 69,355 | 83,614 | 41,255 | 48,958 | 52,242 |
Operating Income | -14,696 | -28,112 | 7,269 | -8,780 | -22,086 |
Interest Expense | 1,250 | -236 | 2,102 | 1,754 | 1,789 |
Other Income | -3,210 | 15,369 | 703 | 148 | 13 |
Pre-tax Income | -19,156 | -12,506 | 5,870 | -10,386 | -23,861 |
Income Tax | 293 | 18,046 | -1,465 | -2,701 | -2,221 |
Net Income Continuous | -19,449 | -30,553 | 7,335 | -7,685 | -21,641 |
Net Income | $-19,449 | $-30,553 | $7,335 | $-7,685 | $-21,641 |
EPS Basic Total Ops | -0.40 | -0.63 | 0.15 | -0.18 | -0.50 |
EPS Basic Continuous Ops | -0.40 | -0.64 | 0.16 | -0.17 | -0.49 |
EPS Diluted Total Ops | -0.40 | -0.62 | 0.14 | -0.18 | -0.50 |
EPS Diluted Continuous Ops | -0.40 | -0.62 | 0.14 | -0.17 | -0.49 |
EPS Diluted Before Non-Recurring Items | -0.43 | -0.63 | 0.14 | N/A | N/A |
EBITDA(a) | $-13,744 | $-28,423 | $8,751 | $-6,868 | $-19,833 |